Burn surgery infection risk: do antibiotics help or hurt?
NCT ID NCT04292054
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether giving antibiotics before burn surgery lowers the chance of infections after the operation. About 506 adults with burns covering 5% to 40% of their body will take part. Half will get antibiotics before surgery, and half will get a placebo. The goal is to see if antibiotics reduce infections, sepsis, or the need for another skin graft.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 3
Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.
- Participants
-
About 506 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Oct 2020
- Expected to finish
-
Jul 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 99 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patient over 18 years and less than 80 years old * Burned patients requiring at least one excision-graft surgery * Burn TBSA% between 5% and 40% * Signed informed consent or inclusion under the emergency provisions of the law (article L1122-1-2 of the CSP) Exclusion Criteria: * Proven severe allergy to cephalosporin or piperacilline-tazobactam or any other antibacterial agent of the penicillin class * History of severe allergic reaction to any other beta-lactam (eg cephalosporins, monobactams or carbapenems). * Patient on antibiotic therapy at the time of surgery * Pregnant or breast-feeding patient * Patient not covered by the social security * Patient transferred from another burn Unit * Patient participant in investigational competitive medicinal product study on the primary endpoint * Patient with local or systemic signs of infection requiring systemic antimicrobial therapy * Patient under guardianship * Patient under curatorship * known colonization of the burned area to be excised with tazocillin-resistant germ. * obese patient with BMI \> 50 kg/m²
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Burn injury are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Saint Louis Hospital
RECRUITINGParis, 75010, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can burn Survivors' bodies handle heat? a trial puts Work-Rest cycles to the test
- Can an enzyme gel dissolve burned tissue without surgery?
- Can a sugar pill curb the opioid crisis?
- Which burn score best predicts who will survive?
- AI learns to see burns on hands, head, and feet
- Border-Region study investigates whether nationality affects burn survival